← Open Payments lookup

KEERTHIGA RAVEENDRAN: Open Payments

NPI 1205350741 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$913 in 47 payments from 11 companies in 2025. Trend: 2023 $668 · 2024 $504 · 2025 $913

Food & beverage: $913
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$176
Janssen Pharmaceuticals, Inc8$159
Teva Pharmaceuticals USA, Inc.5$99
Alkermes, Inc.5$95
Axsome Therapeutics, Inc.4$92
Otsuka America Pharmaceutical, Inc.4$87
E.R. Squibb & Sons, L.L.C.4$78
Luye Pharma (USA) Ltd.3$76
Vanda Pharmaceuticals Inc.1$18
Corium, LLC1$17

Products named: INGREZZA, INVEGA SUSTENNA, AUSTEDO XR, ARISTADA, Auvelity, COBENFY, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII.

Industry payments across LA — which companies pay providers there.